These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 11463767
1. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade. Tom B, de Vries R, Saxena PR, Danser AH. Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767 [Abstract] [Full Text] [Related]
2. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction. van Esch JH, Tom B, Dive V, Batenburg WW, Georgiadis D, Yiotakis A, van Gool JM, de Bruijn RJ, de Vries R, Danser AH. Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077 [Abstract] [Full Text] [Related]
3. Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Tom B, Dendorfer A, de Vries R, Saxena PR, Jan Danser AH. Br J Pharmacol; 2002 Sep; 137(2):276-84. PubMed ID: 12208785 [Abstract] [Full Text] [Related]
10. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart. Anning PB, Grocott-Mason RM, Lewis MJ. Endothelium; 1997 Jul; 5(4):265-75. PubMed ID: 9588818 [Abstract] [Full Text] [Related]
11. Inhibition of neutral endopeptidase by thiorphan does not modify coronary vascular responses to angiotensin I, angiotensin II and bradykinin in the isolated guinea pig heart. Kozlovski VI, Lomnicka M, Jakubowski A, Chlopicki S. Pharmacol Rep; 2007 Jul; 59(4):421-7. PubMed ID: 17901571 [Abstract] [Full Text] [Related]